BDBM50234382 4-methyl-3-(piperidin-1-ylsulfonyl)-N-o-tolylbenzamide::CHEMBL253259
SMILES: Cc1ccccc1NC(=O)c1ccc(C)c(c1)S(=O)(=O)N1CCCCC1
InChI Key: InChIKey=DCXSNSMWJTWHKI-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50234382 (4-methyl-3-(piperidin-1-ylsulfonyl)-N-o-tolylbenza...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 154 | n/a | n/a | n/a | n/a |
Evotec (UK) Ltd. Curated by ChEMBL | Assay Description Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP level | Bioorg Med Chem Lett 18: 1725-9 (2008) Article DOI: 10.1016/j.bmcl.2008.01.042 BindingDB Entry DOI: 10.7270/Q2X92B1F | |||||||||||
More data for this Ligand-Target Pair |